focus has been given to understanding the sources and mechanisms that underlie this response 27 for the purpose of deliberately increasing circulating levels of BDNF. Here we review evidence 28 to support that exploiting these mechanisms of BDNF release can help to optimize brain 29 plasticity outcomes via exercise interventions, which could be especially relevant in the context 30 of multimodal training (i.e., exercise and cognitive stimulation). Therefore, the purpose of this 31 paper is to review the candidate sources of BDNF during exercise and the mechanisms of 32 release. As well, we discuss strategies for maximizing BDNF responses to exercise, and propose 33 novel research directions for advancing our understanding of these mechanisms. 34 35
focus has been given to understanding the sources and mechanisms that underlie this response 27 for the purpose of deliberately increasing circulating levels of BDNF. Here we review evidence 28 to support that exploiting these mechanisms of BDNF release can help to optimize brain 29 plasticity outcomes via exercise interventions, which could be especially relevant in the context 30 of multimodal training (i.e., exercise and cognitive stimulation). Therefore, the purpose of this 31 paper is to review the candidate sources of BDNF during exercise and the mechanisms of 32 release. As well, we discuss strategies for maximizing BDNF responses to exercise, and propose 33 novel research directions for advancing our understanding of these mechanisms. Given the beneficial effects of exercise on the brain and that BDNF is a prime candidate 84 molecule for mediating these effects, it would seem imperative to understand how exercise 85 elevates BDNF in order to inform the development of the most effective modalities of exercise 86 for maximizing circulating BDNF. However, little attention has been paid to understanding and 87 connecting the mechanisms by which exercise might elevate BDNF to a given exercise modality. 88
This is a critical shortcoming of the current body of literature, in that it prevents mechanism-89 based development of effective exercise modalities for maximizing BDNF. Understanding these 90 mechanisms may have functional implications for an array of populations, and can strengthen the 91 rationale and design of exercise interventions focused on improving brain health. Therefore, the 92 purpose of this review is to 1) identify potential contributors to circulating BDNF with exercise 93 and the mechanisms responsible for these contributions, and 2) to apply this knowledge to the 94 design of exercise interventions that are effective at elevating circulating BDNF. This review 95 focuses specifically on BDNF responses to 'exercise', which is planned, structured, and 96 repetitive body movement that increases energy expenditure with the objective of improving or 97 maintaining fitness, as opposed to 'physical activity', which refers to any bodily movement that 98 increases energy expenditure (>1.5 metabolic equivalents) above resting levels (Caspersen et al. The bulk of available evidence has primarily focused on acute aerobic exercise 115 paradigms; however, it appears as though both acute aerobic and resistance exercise modalities 116 are effective at increasing circulating BDNF (Dinoff et al. 2017). The aspects of exercise that 117 drive the BDNF response are equivocal, as one systematic review suggests BDNF increases in an 118 intensity-dependent manner (Knaepen et al. 2010 ), whereas others report that exercise duration 119 drives this response (Dinoff et al. 2017). Regardless, this effect is relatively short lived 120 following cessation from exercise as levels return to baseline levels within 30 minutes for serum 121 (Yarrow et al. 2010 , Walsh et al. 2016 ) and 60 minutes for plasma (Gilder et al. 2014) . 122
Moreover, chronic exercise training has equivocal and highly variable effects on resting BDNF 123 that a period of aerobic, but not resistance training, increases resting serum and plasma BDNF; 125 however, only half of the reported studies (9/18) observed an increase in resting BDNF -an 126 effect that was largely driven by studies that included populations that are known to have lower 127 basal BDNF (i.e., Parkinson's disease, obesity, and metabolic syndrome). 
Sources and Mechanisms of BDNF Release during Exercise 156
The addition of BDNF to the blood at rest and during exercise is likely derived from a 157 number of tissue sources that produce and release the neurotrophin into circulation in response to 158 exercise-like stimuli. BDNF was originally purified in homogenized pig brain where it was 159 recognized for its role in the growth and survival of sensory neurons (Barde et al. 1982) ; 160 however, referring to this neurotrophin as "brain-derived" is somewhat misleading as it has been 161 established that a host of tissues produce and release BDNF, in addition to the brain. These 
Peripheral Blood Mononuclear Cells 261
In addition to its neurogenic effects, BDNF also has a role in immunity and tissue repair. 
Sources of Serum BDNF 323

Platelets 324
The aforementioned tissue sources contribute to the serum pool by adding directly to 325 plasma, given that serum measures quantify the combined plasma (unbound) and platelet 326 (bound) BDNF pools (Figure 1) . By far the greater portion of serum BDNF comes from 327 platelets, as they are the primary transporter of BDNF in the blood and contain 99% of total 328 blood-borne BDNF. Importantly, there are extremely low levels of BDNF mRNA in platelets, 329 D r a f t (Fujimura et al. 2002) , suggesting that platelet-bound BDNF is derived from both 336 megakaryocytes and sequestered in the blood from cellular sources (Figure 2) . 337
The role of platelets in BDNF dynamics is often viewed as purely a storage compartment 338 and is overlooked in the context of increasing BDNF via exercise for improving brain health. 339
However, platelets not only sequester and store the majority of circulating BDNF, they also 340 rapidly release BDNF in a dose-response manner to both pharmacological (antidepressants) 341 While the relative contribution of platelets and tissue sources cannot be isolated, the 383 increase in BDNF per platelet likely represents cellular sources rather than from splenic platelets 384 with a higher BDNF content than circulating platelets. The spleen is constantly exchanging 385 circulating and stored platelets, and these pools do not differ in age or cellular content 386 
Target the Spleen -a one-armed example 420
The contribution of the splenic platelets to serum BDNF has important implications for 421 exercise interventions that are designed to increase blood-borne BDNF. Recently, we undertook 422 a study that tested the hypothesis that an exercise protocol capable of evoking thrombocytosis 423 should be capable of increasing serum BDNF (Walsh et al. 2017) . Given that thrombocytosis 424 occurs with increased sympathetic activation, any intervention that can stimulate this mechanismD r a f t should be able to evoke increases in serum BDNF, independent of total metabolic cost or the size 426 of muscle mass involved (Walsh et al. 2017 ). Small muscle mass exercise, such as forearm 427 handgrip exercise can substantially increase sympathetic activation (Joyner et al. 1992 ) and very 428 brief, sustained handgrip exercise (MVC) causes splenic constriction and a small thrombocytosis 429 (Frances et al. 2008) . Accordingly, we hypothesized that forearm handgrip exercise should be 430 capable of increasing serum BDNF through mechanisms of increased platelets due to 431
thrombocytosis. 432
To test this hypothesis, we had participants perform 10 minutes of maximal effort and 30 433 minutes of submaximal effort forearm handgrip exercise and measured serum BDNF and 434 platelets (plasma determination was unsuccessful; see Walsh et al. 2017 ). We found that forearm 435 handgrip exercise increased circulating platelets in an intensity-dependent manner, and this was 436 accompanied by a substantial increase in serum BDNF, although an exercise intensity effect was isolates two mechanisms known to increase BDNF while eliminating the contribution of platelets 468 from the spleen. Given that we are unable to elucidate the relative contribution of shear stress 469 versus hyperthermia to the increase in BDNF from this study, future studies are tasked with 470 determining the relative contribution of these mechanisms. This raises unique opportunities for 471 D r a f t strategically targeting the cardiovascular system via exercise and non-exercise modalities for 472 systemically increasing BDNF, and targeting cerebrovascular microcirculation via cognitive 473 activation thereby increasing local shear stress and the delivery of BDNF to active tissue. 474
Hypotheses Worth Testing 476
The bulk of exercise and BDNF research to date has focused on whether exercise 477 increases circulating levels and if there is a relationship between changes in BDNF and cognitive 478 function in response to acute and chronic exercise. While the latter focus is still in its relatively 479 Sympathoexcitation causes thrombocytosis, which leads to an increase in serum BDNF 495 via platelets; however, this phenomenon has not been studied in isolation. Accordingly, 496
investigations that utilize maneuvers other than exercise to increase SNA would allow for the 497 isolation of the splenic platelet contribution to serum only without addition from cellular sources. 498
We have performed pilot work investigating the ability the cold-pressor test (CPT) and the 499 muscle metaboreflex (MMR) -known SNA maneuvers -to increase serum BDNF. While we 500 were underpowered (n=8) for these investigations, we observed no thrombocytosis with the CPT 501 and a small increase in platelets with MMR that was not statistically significant (2.01%; p = 502 0.26). While there was predictably no response to CPT, serum BDNF increased by 8.5% in 503 response to the MMR test, which trended towards statistical significance (p = 0.06). 504
Accordingly, future studies should perform an adequately powered study that can evoke more 505 robust increases in circulating platelets in response to sympathoexcitation protocol. 506
507
Is the BDNF response affected by repeated bouts of exercise within a short time frame? 508
Given that acute exercise increases the amount of BDNF per platelet, the subsequent 509 reuptake of platelets by the spleen following exercise theoretically should contain a higher 510 BDNF content. With that in mind, would a second bout of exercise performed within a short 511 time frame (hours) result in a greater BDNF response compared to the first bout? 512
In the same manner that arteriovenous differences are measured across the brain, the 515 same model can be applied to an exercising limb. The effluent from a deep vein draining an 516 active muscle may contain higher plasma BDNF due to endothelial cell and platelet release in 517 D r a f t 24 response to high shear stress and reductions in PO 2 . Such an analysis would need to measure 518 serum, plasma, and platelets in order to compare the local versus systemic levels of BDNF 519 during exercise. Measuring arteriovenous differences across a single limb would also allow for 520 the manipulation of specific BDNF-releasing mechanisms, such as shear stress, hyperthermia, 521 and hypoxia. We have previously attempted to use this model using an exercising forearm; 522 however, we were unsuccessful at measuring plasma in our samples and could not make this 523
comparison (Walsh et al. 2017 ). Nonetheless, isolating and manipulating non-brain sources of 524 BDNF would advance our understanding of these mechanisms. 525
526
Conclusions 527
The mechanisms by which exercise orchestrates structural and functional adaptations in 528 the brain are diverse and not well understood in humans. Despite enthusiasm for the actions of 529 BDNF as a candidate mechanism, previous investigations have primarily focused on whether 530 exercise increases circulating levels rather than how this is achieved. By considering the sources 531 and mechanisms of BDNF release with exercise, researchers and clinical exercise practitioners 532 can strategically design exercise and behavioural interventions that maximize BDNF exposure 533 and delivery to the brain. This research is still in its infancy and will require a concerted, 534 systematic effort to establish the relative contribution of individual tissue sources and to test the 535 hypotheses proposed in this review. 536 537
Conflict of Interest Statement 538
The authors do not have any conflicts of interest to report. Sources of BDNF addition and removal from the circulating pool (from left to right): BDNF can be added to the circulating pool via tissue sources and through the addition of platelets to the blood via thrombocytosis (splenic constriction and platelet release). Circulating BDNF can move between the platelet-bound and the plasma pools in response to specific physiological stimuli. Plasma (free) BDNF can be removed from the blood by acting on the TrkB receptor and platelet-bound BDNF can be removed from the blood via the reuptake of platelets by the spleen.
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Schematic of the interactions between peripheral BDNF (bound and free), exercise-dependent stimuli, and endothelial cells of the cerebral microvasculature. From right to left: Unbound, circulating BDNF accesses neural tissue by directly crossing the BBB, and the myokine irisin may enter the brain and stimulate hippocampal BDNF expression. BDNF can also cross the BBB from the brain to the blood and increase circulating levels. Unbound circulating BDNF also acts on the TrkB receptor on the vascular endothelium, which stimulates the upregulation of BDNF production via eNOS activity. Newly formed endothelial BDNF has two plausible fates: 1) enter the brain via neurotrophic coupling, or 2) be released into circulation via exocytosis in response to exercise-like stimuli, including shear stress and reductions in PO2. Platelets release BDNF in response to shear stress and agonist stimuli including ADP, thrombin, collagen, and epinephrine, which increases the local concentration and therefore, the likelihood of circulating BDNF interacting with the TrkB receptor. Platelets also sequester BDNF via very-high and moderate affinity receptors in the absence of these stimuli. ADP = adenosine diphosphate, BBB = blood-brain barrier, eNOS = endothelial nitric oxide synthase, TrkB = tropomyosin-related kinase B.
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